pulmonary hypertension – pharmaceutical daily

February 12, 2018 Off

Bardoxolone methyl improves kidney functions for pulmonary arterial hypertension patients, Reata study suggests

Reata Pharmaceuticals has reported that its study that shows bardoxolone methyl can improve kidney functions for patients with pulmonary arterial…

April 12, 2017 Off

Respira Therapeutics, United Therapeutics Corporation join to fight pulmonary hypertension

By Dino Mustafić

Respira Therapeutics, a privately held pharmaceutical company developing innovative inhaled therapies to treat pulmonary hypertension and other pulmonary diseases, has entered into a strategic collaboration with United Therapeutics Corporation for the development and exclusive license of Respira’s inhaled drug-device product, RT234, for pulmonary hypertension indications in North America.